Biolog Device Co., Ltd. (KOSDAQ: 208710)
South Korea
· Delayed Price · Currency is KRW 387.00
-10.00 (-2.52%)
Nov 15, 2024, 9:00 AM KST
Biolog Device Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Operating Revenue | 142,348 | 123,469 | 104,283 | 83,834 | 91,793 | 90,419 | Upgrade
|
| Other Revenue | 0 | - | - | -0 | - | - | Upgrade
|
| Revenue | 142,348 | 123,469 | 104,283 | 83,834 | 91,793 | 90,419 | Upgrade
|
| Revenue Growth (YoY) | 39.12% | 18.40% | 24.39% | -8.67% | 1.52% | 10.99% | Upgrade
|
| Cost of Revenue | 137,720 | 118,898 | 95,715 | 80,555 | 87,522 | 70,747 | Upgrade
|
| Gross Profit | 4,628 | 4,571 | 8,568 | 3,279 | 4,271 | 19,672 | Upgrade
|
| Selling, General & Admin | 7,592 | 6,696 | 6,823 | 7,914 | 6,581 | 7,624 | Upgrade
|
| Research & Development | - | - | 54.52 | 1,257 | 1,344 | 1,473 | Upgrade
|
| Other Operating Expenses | 139.49 | 80.87 | 115.98 | 216.46 | 112.55 | 118.82 | Upgrade
|
| Operating Expenses | 10,611 | 9,633 | 7,893 | 13,087 | 8,589 | 12,675 | Upgrade
|
| Operating Income | -5,983 | -5,062 | 674.99 | -9,808 | -4,318 | 6,997 | Upgrade
|
| Interest Expense | -1,302 | -1,818 | -1,930 | -2,054 | -1,816 | -1,188 | Upgrade
|
| Interest & Investment Income | 603.77 | 730.86 | 299.7 | 175.35 | 44.79 | 69.67 | Upgrade
|
| Earnings From Equity Investments | -448.08 | -690.29 | -209.71 | 4,309 | -9,136 | 610.26 | Upgrade
|
| Currency Exchange Gain (Loss) | 717.41 | -77.55 | 1,768 | 1,921 | -962.42 | 1,355 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,349 | -78.3 | -709.88 | -3,849 | -379.91 | -614.75 | Upgrade
|
| EBT Excluding Unusual Items | -7,760 | -6,995 | -106.94 | -9,306 | -16,567 | 7,229 | Upgrade
|
| Impairment of Goodwill | - | - | -151.66 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,171 | 1,171 | 120.43 | - | - | 1.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2,203 | -1,855 | 5,629 | 210.57 | 45.23 | 89.09 | Upgrade
|
| Asset Writedown | -153.75 | -153.75 | -603.44 | -88.49 | - | -291.45 | Upgrade
|
| Pretax Income | -8,946 | -7,833 | 4,888 | -9,184 | -16,522 | 7,028 | Upgrade
|
| Income Tax Expense | 1,425 | 155.32 | 3,067 | -1,281 | 373.49 | 893.36 | Upgrade
|
| Earnings From Continuing Operations | -10,371 | -7,989 | 1,820 | -7,903 | -16,895 | 6,135 | Upgrade
|
| Earnings From Discontinued Operations | -5,227 | -5,737 | -1,422 | 16.82 | - | - | Upgrade
|
| Net Income to Company | -15,598 | -13,726 | 398.28 | -7,887 | -16,895 | 6,135 | Upgrade
|
| Minority Interest in Earnings | 1,658 | 1,916 | -140.9 | 672.91 | - | 10.48 | Upgrade
|
| Net Income | -13,940 | -11,810 | 257.38 | -7,214 | -16,895 | 6,146 | Upgrade
|
| Net Income to Common | -13,940 | -11,810 | 257.38 | -7,214 | -16,895 | 6,146 | Upgrade
|
| Net Income Growth | - | - | - | - | - | 4.35% | Upgrade
|
| Shares Outstanding (Basic) | 57 | 47 | 42 | 38 | 29 | 28 | Upgrade
|
| Shares Outstanding (Diluted) | 57 | 47 | 42 | 38 | 29 | 33 | Upgrade
|
| Shares Change (YoY) | 34.94% | 12.37% | 9.39% | 32.86% | -14.20% | -2.89% | Upgrade
|
| EPS (Basic) | -244.59 | -251.99 | 6.17 | -189.19 | -588.69 | 218.78 | Upgrade
|
| EPS (Diluted) | -244.59 | -251.99 | 6.17 | -189.19 | -588.69 | 203.22 | Upgrade
|
| EPS Growth | - | - | - | - | - | 4.98% | Upgrade
|
| Free Cash Flow | -758.74 | 3,657 | 3,107 | -5,723 | -19,966 | 14,235 | Upgrade
|
| Free Cash Flow Per Share | -13.31 | 78.03 | 74.49 | -150.11 | -695.70 | 425.57 | Upgrade
|
| Gross Margin | 3.25% | 3.70% | 8.22% | 3.91% | 4.65% | 21.76% | Upgrade
|
| Operating Margin | -4.20% | -4.10% | 0.65% | -11.70% | -4.70% | 7.74% | Upgrade
|
| Profit Margin | -9.79% | -9.57% | 0.25% | -8.60% | -18.41% | 6.80% | Upgrade
|
| Free Cash Flow Margin | -0.53% | 2.96% | 2.98% | -6.83% | -21.75% | 15.74% | Upgrade
|
| EBITDA | 2,196 | 3,233 | 8,627 | -1,908 | 4,633 | 14,735 | Upgrade
|
| EBITDA Margin | 1.54% | 2.62% | 8.27% | -2.28% | 5.05% | 16.30% | Upgrade
|
| D&A For EBITDA | 8,179 | 8,295 | 7,952 | 7,900 | 8,951 | 7,738 | Upgrade
|
| EBIT | -5,983 | -5,062 | 674.99 | -9,808 | -4,318 | 6,997 | Upgrade
|
| EBIT Margin | -4.20% | -4.10% | 0.65% | -11.70% | -4.70% | 7.74% | Upgrade
|
| Effective Tax Rate | - | - | 62.76% | - | - | 12.71% | Upgrade
|
| Advertising Expenses | - | 0.35 | 16.95 | 2.88 | 47.67 | 78.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.